• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Protein Sci . Biophysical Investigation of Interactions Between SARS-CoV-2 Spike Protein and Neuropilin-1

tetano

Editor, Senior Moderator
Protein Sci


. 2023 Sep 1;e4773.
doi: 10.1002/pro.4773. Online ahead of print. Biophysical Investigation of Interactions Between SARS-CoV-2 Spike Protein and Neuropilin-1

Decheng Hou[SUP] 1 2 [/SUP], Wenpeng Cao[SUP] 1 [/SUP], Seonghan Kim[SUP] 1 [/SUP], Xinyu Cui[SUP] 1 2 [/SUP], Matthew Ziarnik[SUP] 1 [/SUP], Im Wonpil[SUP] 1 [/SUP], X Frank Zhang[SUP] 1 2 [/SUP]



Affiliations
Abstract

Recent studies have suggested that neuropilin-1 (NRP1) may serve as a potential receptor in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. However, the biophysical characteristics of interactions between NRP1 and SARS-CoV-2 remain unclear. In this study, we examined the interactions between NRP1 and various SARS-CoV-2 spike (S) fragments, including the receptor-binding domain (RBD) and the S protein trimer in a soluble form or expressed on pseudovirions, using atomic force microscopy (AFM) and structural modeling. Our measurements showed that NRP1 interacts with the RBD and trimer at a higher binding frequency compared to ACE2. This NRP1-RBD interaction has also been predicted and simulated via AlphaFold2 and molecular dynamic simulations, and the results indicate that their binding patterns are very similar to RBD-ACE2 interactions. Additionally, under similar loading rates, the most probable unbinding forces between NRP1 and S trimer (both soluble form and on pseudovirions) are larger than the forces between NRP1 and RBD and between trimer and ACE2. Further analysis indicates that NRP1 has a stronger binding affinity to the SARS-CoV-2 S trimer with a dissociation rate of 0.87 s[SUP]-1[/SUP] , four times lower than the dissociation rate of 3.65 s[SUP]-1[/SUP] between NRP1 and RBD. Moreover, additional experiments show that RBD-neutralizing antibodies can significantly reduce the binding frequency for both ACE2 and NRP1. Together, the study suggests that NRP1 can be an alternative receptor for SARS-CoV-2 attachment to human cells, and the neutralizing antibodies targeting SARS-CoV-2 RBD can reduce the binding between SARS-CoV-2 and NRP1. This article is protected by copyright. All rights reserved.

Keywords: AlphaFold; MD simulation; SARS-CoV-2; force microscopy; neuropilin-1; virus-host cell interaction.

 
Back
Top Bottom